Generation of a Nonbilayer Lipid Nanoenvironment after Epitope Binding Potentiates Neutralizing HIV-1 MPER Antibody.

HIV-1 antibody antibody engineering antibody-membrane interaction lipid nanoenvironment membrane deformation metadynamics molecular dynamics simulations site-selective chemical modification

Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
24 Oct 2024
Historique:
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 24 10 2024
Statut: aheadofprint

Résumé

Establishment of interactions with the envelope lipids is a cardinal feature of broadly neutralizing antibodies (bnAbs) that recognize the Env membrane-proximal external region (MPER) of HIV. The lipid envelope constitutes a relevant component of the full "quinary" MPER epitope, and thus antibodies may be optimized through engineering their capacity to interact with lipids. However, the role of the chemically complex lipid nanoenvironment in the mechanism of MPER molecular recognition and viral neutralization remains poorly understood. To approach this issue, we computationally and experimentally investigated lipid interactions of broadly neutralizing antibody 10E8 and optimized versions engineered to enhance their epitope and membrane affinity by grafting bulky aromatic compounds. Our data revealed a correlation between neutralization potency and the establishment of favorable interactions with small headgroup lipids cholesterol and phosphatidylethanolamine, evolving after specific engagement with MPER. Molecular dynamics simulations of chemically modified Fabs in complex with an MPER-Transmembrane Domain helix supported the generation of a nanoenvironment causing localized deformation of the thick, rigid viral membrane and identified sphingomyelin preferentially occupying a phospholipid-binding site of 10E8. Together, these interactions appear to facilitate insertion of the Fabs through their engagement with the MPER epitope. These findings implicate individual lipid molecules in the neutralization function of MPER bnAbs, validate targeted chemical modification as a method to optimize MPER antibodies, and suggest pathways for MPER peptide-liposome vaccine development.

Identifiants

pubmed: 39446590
doi: 10.1021/acsami.4c13353
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Sara Insausti (S)

Instituto Biofisika (CSIC, UPV/EHU), University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.
Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.

Ander Ramos-Caballero (A)

Instituto Biofisika (CSIC, UPV/EHU), University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.

Brian Wiley (B)

Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AX, United Kingdom.

Saul González-Resines (S)

Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AX, United Kingdom.

Johana Torralba (J)

Instituto Biofisika (CSIC, UPV/EHU), University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.
Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.

Anne Elizaga-Lara (A)

Instituto Biofisika (CSIC, UPV/EHU), University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.
Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.

Christine Shamblin (C)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California 92037, United States.

Akio Ojida (A)

Department of Chemical Biology, School of Pharmaceutical Sciences, Kyushu University, Fukuoka 819-0395, Japan.

Jose M M Caaveiro (JMM)

Laboratory of Protein Drug Discovery, School of Pharmaceutical Sciences, Kyushu University, Fukuoka 819-0395, Japan.

Michael B Zwick (MB)

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, California 92037, United States.

Edurne Rujas (E)

Instituto Biofisika (CSIC, UPV/EHU), University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.
Department of Pharmacy and Food Sciences, Faculty of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria 01006, Spain.
Basque Foundation for Science, Ikerbasque, Bilbao48013, Spain.

Carmen Domene (C)

Department of Chemistry, University of Bath, Claverton Down, Bath BA2 7AX, United Kingdom.

José L Nieva (JL)

Instituto Biofisika (CSIC, UPV/EHU), University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.
Department of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), P.O. Box 644, Bilbao 48080, Spain.

Classifications MeSH